Van-Phong Bui

Nhà nghiên cứu Hồ sơ 4/10

Anova Corp (Vietnam) · Y - Dược

4 công bố · 1 trích dẫn · h-index 1

Thông tin

🏛️Nơi công tác: Anova Corp (Vietnam)
🔬Lĩnh vực: Y - Dược
✍️Hồ sơ chưa đầy đủ — bổ sung thông tin

Công bố tiêu biểu

Tyrosine kinase inhibitors in first-line treatment of advanced NSCLC with epidermal growth factor receptor mutations: Real-world data from Vietnam1 trích dẫn
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2025 · DOI

Laboratory evaluation of the iPonatic molecular point-of-care test for group B Streptococcus detection in pregnant Vietnamese women
Current Research in Biotechnology · 2026 · DOI

Comparing Molecular Point-of-Care Testing and Real-Time PCR for Group B Streptococcus Detection in Pregnant Vietnamese Women
SSRN Electronic Journal · 2025 · DOI

Brain metastases in non-small cell lung cancer: Prevalence, high-risk factors, and overall survival prognosis
Forum of Clinical Oncology · 2025 · DOI

Về lĩnh vực Y - Dược

6.619học giả

91.896công bố

2.589.484trích dẫn

4.2h-index trung bình

Hướng nghiên cứu phổ biến trong lĩnh vực:

Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions

Nơi có nhiều học giả lĩnh vực này nhất: